Arbutus Biopharma Corp (ABUS) Capital expenditures 2016–2025
Arbutus Biopharma Corp (ABUS) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$0FY2025 · since FY2016: $4.0M → $0
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $0 | -100.0% |
| FY2024 | $182,000 | -81.9% |
| FY2023 | $1.0M | +96.9% |
| FY2022 | $512,000 | -36.7% |
| FY2021 | $809,000 | +253.3% |
| FY2020 | $229,000 | -61.1% |
| FY2019 | $589,000 | -48.2% |
| FY2018 | $1.1M | -84.3% |
| FY2017 | $7.3M | +81.8% |
| FY2016 | $4.0M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice